XEOMEEN (XEOMIN®) 100u (Spanish)

Description

Name: XEOMEEN (XEOMIN®) 100u (Spanish)
Manufacturer: Merz Pharma
Active Substance(s): INCA-BOTULINUM TOXIN
Package Content: 100u

XEOMEEN, internationally known as XEOMIN®, is a botulinum neurotoxin type A used for both aesthetic and therapeutic applications. It is designed to temporarily block the release of acetylcholine, thereby reducing muscle contraction and softening dynamic wrinkles.

What sets XEOMEEN apart is its purified formulation—it contains only the active neurotoxin without complexing proteins, which may reduce the risk of antibody resistance. This 100-unit vial is suitable for both facial aesthetic treatments and neurological disorders involving muscle spasticity.

Key Features:

• 100 Units of purified botulinum toxin type A per vial (without complexing proteins)

• Used to treat glabellar lines, blepharospasm, cervical dystonia, and more

• High purity formula may lower risk of immune response over time

XEOMEEN is supplied in a clear glass vial as a lyophilized powder for reconstitution. The product must be reconstituted with sterile saline before injection.

Each package contains:

• 1 vial with 100 units of botulinum toxin A (Clostridium botulinum neurotoxin)

• No preservatives or complexing proteins

• Supplied as a single-dose vial

Ingredients per vial:

• Botulinum neurotoxin type A: 100 units

• Human albumin: 1 mg

• Sucrose: 4.7 mg

No animal-derived components are present in the formulation, which enhances safety for sensitive individuals.

XEOMEEN is indicated for both aesthetic and therapeutic purposes. In aesthetic medicine, it is primarily used to reduce moderate to severe glabellar frown lines. Therapeutically, it treats several muscle-related neurological conditions.

Aesthetic Indications:

• Glabellar lines (frown lines between the eyebrows) in adults under 65 years of age

Therapeutic Indications:

• Blepharospasm (eyelid spasms)

• Cervical dystonia (abnormal neck muscle tone)

• Spasticity of upper limbs post-stroke

• Chronic sialorrhea (excessive drooling)

Contraindications:

• Hypersensitivity to botulinum toxin A or excipients

• Presence of infection at the injection site

• Diagnosed neuromuscular disorders (e.g., myasthenia gravis, Lambert-Eaton syndrome)

Common Side Effects:

• Headache, drooping eyelids (ptosis)

• Localized pain, redness, or swelling at injection site

• Dry eyes, dry mouth, muscle weakness

Serious but Rare Side Effects:

• Difficulty breathing or swallowing

• Allergic reactions (anaphylaxis, rash)

XEOMEEN must be administered by a trained healthcare professional familiar with botulinum toxin injections. It is delivered through intramuscular injection, typically in small doses across multiple points depending on the condition treated.

Administration Guidelines:

• Reconstitute with sodium chloride 0.9%

• Typical glabellar line dose: 20 units total, divided across 5 sites

• Do not exceed 50 units for glabellar lines in a single session

• Therapeutic doses vary by indication and muscle mass

• Onset of action: 2–4 days; peak effect at 7–14 days

• Duration: up to 12–16 weeks

Storage Instructions:

• Unopened vials: Store at 2°C–8°C (refrigerated)

• After reconstitution: Use within 24 hours

• Protect from light; do not freeze

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.